[
  {
    "generic_name": "Ketamine",
    "brand_names": ["Ketalar", "Ketaject", "Ketanest"],
    "active_ingredients": "Ketamine Hydrochloride 50mg/ml",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-8001",
    "nafdac_schedule": "schedule_4",
    "nafdac_schedule_date": "2016-01-01",
    "us_dea_schedule": "Schedule III",
    "uk_controlled_drug_class": "Class B",
    "who_essential_medicine": true,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 3,
    "requires_photo_id": false,
    "therapeutic_class": "Dissociative Anesthetic",
    "pharmacological_class": "NMDA Receptor Antagonist",
    "mechanism_of_action": "Non-competitive NMDA receptor antagonist, produces dissociative anesthesia",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Blood pressure, Heart rate, Respiratory function, Emergence reactions, Abuse signs",
    "monitoring_frequency_days": 1,
    "addiction_risk": true,
    "abuse_potential": "high",
    "minimum_age": null,
    "maximum_age": null,
    "pregnancy_category": "B",
    "breastfeeding_safe": false,
    "major_contraindications": ["Severe hypertension", "Stroke", "Increased intracranial pressure", "Severe cardiac disease", "Psychiatric conditions with hallucinations"],
    "allergy_cross_reactions": ["None known"],
    "black_box_warning": false,
    "black_box_warning_text": "",
    "major_drug_interactions": ["CNS depressants (enhanced sedation)", "Sympathomimetics (hypertensive crisis)", "Thyroid hormones (hypertension, tachycardia)"],
    "food_interactions": "Avoid alcohol",
    "search_keywords": ["ketamine", "ketalar", "special k", "anesthesia", "dissociative", "pain management", "depression"],
    "generic_variations": ["Ketamine Hydrochloride"],
    "common_misspellings": ["Ketamin", "Ketalar", "Catamine"],
    "safer_alternatives": ["Propofol for anesthesia", "Esketamine (nasal) for depression"],
    "cheaper_alternatives": ["Thiopental (less safe)"],
    "notes": "Dissociative anesthetic used for procedural sedation, anesthesia induction, and severe pain. Unique property: maintains airway reflexes and respiratory drive. Causes psychedelic emergence reactions (hallucinations, out-of-body experiences). High abuse potential as club drug ('Special K'). Recently approved as nasal spray (esketamine) for treatment-resistant depression. Increases blood pressure and heart rate. NAFDAC-controlled since 2016 due to abuse.",
    "is_active": true
  },
  {
    "generic_name": "Methylphenidate",
    "brand_names": ["Ritalin", "Concerta", "Metadate"],
    "active_ingredients": "Methylphenidate HCl 10mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-8002",
    "nafdac_schedule": "schedule_4",
    "nafdac_schedule_date": "2012-01-01",
    "us_dea_schedule": "Schedule II",
    "uk_controlled_drug_class": "Class B",
    "who_essential_medicine": false,
    "requires_special_prescription": true,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 30,
    "requires_photo_id": true,
    "therapeutic_class": "CNS Stimulant",
    "pharmacological_class": "Dopamine/Norepinephrine Reuptake Inhibitor",
    "mechanism_of_action": "Blocks dopamine and norepinephrine reuptake, increasing synaptic concentrations",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "ADHD symptoms, Growth (in children), Blood pressure, Heart rate, Abuse/diversion signs, Psychiatric symptoms",
    "monitoring_frequency_days": 30,
    "addiction_risk": true,
    "abuse_potential": "high",
    "minimum_age": 6,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": false,
    "major_contraindications": ["Glaucoma", "Severe hypertension", "Hyperthyroidism", "MAOIs within 14 days", "Motor tics or Tourette's syndrome", "Severe anxiety or agitation"],
    "allergy_cross_reactions": ["Other stimulants"],
    "black_box_warning": true,
    "black_box_warning_text": "High potential for abuse and dependence. Misuse may cause sudden death and serious cardiovascular events. Not indicated for normal fatigue. Careful screening for cardiac disease required before prescribing.",
    "major_drug_interactions": ["MAOIs (hypertensive crisis)", "Antihypertensives (reduced effectiveness)", "Warfarin (increased levels)", "SSRIs (serotonin syndrome risk)", "Alcohol"],
    "food_interactions": "Take with or after meals to reduce GI upset, avoid excessive caffeine",
    "search_keywords": ["methylphenidate", "ritalin", "adhd", "add", "stimulant", "attention deficit"],
    "generic_variations": ["Methylphenidate Hydrochloride", "Extended-Release Methylphenidate"],
    "common_misspellings": ["Methylfenidate", "Ritaline", "Methylphenidat"],
    "safer_alternatives": ["Atomoxetine (non-stimulant)", "Guanfacine", "Behavioral therapy"],
    "cheaper_alternatives": ["Dextroamphetamine"],
    "notes": "CNS stimulant for ADHD and narcolepsy. Commonly abused by students for cognitive enhancement. Crushed and snorted or injected for euphoria. May suppress growth in children - monitor height and weight. 'Drug holidays' (stopping on weekends/holidays) sometimes recommended. Cardiovascular screening mandatory before starting. Diversion for non-medical use is common.",
    "is_active": true
  },
  {
    "generic_name": "Dextromethorphan",
    "brand_names": ["Robitussin DM", "Benylin DM", "Delsym"],
    "active_ingredients": "Dextromethorphan Hydrobromide 15mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-8003",
    "nafdac_schedule": "schedule_4",
    "nafdac_schedule_date": "2017-01-01",
    "us_dea_schedule": "Not scheduled (federally), controlled in some states",
    "uk_controlled_drug_class": "Not controlled (P/GSL)",
    "who_essential_medicine": false,
    "requires_special_prescription": false,
    "requires_physician_only": false,
    "pharmacist_can_prescribe": true,
    "maximum_days_supply": 7,
    "requires_photo_id": false,
    "therapeutic_class": "Cough Suppressant",
    "pharmacological_class": "Antitussive",
    "mechanism_of_action": "Acts on cough center in medulla, NMDA receptor antagonist at high doses",
    "is_controlled": true,
    "is_high_risk": false,
    "requires_monitoring": true,
    "monitoring_type": "Cough control, Abuse indicators (especially in adolescents)",
    "monitoring_frequency_days": 7,
    "addiction_risk": true,
    "abuse_potential": "moderate",
    "minimum_age": 12,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": true,
    "major_contraindications": ["MAOIs within 14 days", "Chronic cough (asthma, emphysema)", "Productive cough"],
    "allergy_cross_reactions": ["None known"],
    "black_box_warning": false,
    "black_box_warning_text": "",
    "major_drug_interactions": ["MAOIs (serotonin syndrome, fatal)", "SSRIs (serotonin syndrome)", "CYP2D6 inhibitors (increased levels)", "Quinidine (increased DXM levels)"],
    "food_interactions": "Avoid grapefruit juice, avoid alcohol",
    "search_keywords": ["dextromethorphan", "dxm", "robitussin", "cough syrup", "robotripping"],
    "generic_variations": ["Dextromethorphan Hydrobromide", "Dextromethorphan Polistirex (extended-release)"],
    "common_misspellings": ["Dextromethorphin", "Dextromethorfan", "DXM"],
    "safer_alternatives": ["Honey (for mild cough)", "Codeine (more effective, more controlled)"],
    "cheaper_alternatives": ["Diphenhydramine", "Guaifenesin (expectorant, not suppressant)"],
    "notes": "OTC cough suppressant widely abused by teenagers and young adults for dissociative/hallucinogenic effects ('robotripping', 'skittling'). At high doses (300-1500mg), acts as NMDA antagonist similar to ketamine and PCP. NAFDAC scheduled in 2017 due to abuse epidemic. Four abuse 'plateaus' based on dose. Can cause serotonin syndrome with SSRIs/MAOIs. Age restrictions for purchase in many areas. Often combined with other drugs in multi-ingredient cough/cold products.",
    "is_active": true
  },
  {
    "generic_name": "Pseudoephedrine",
    "brand_names": ["Sudafed", "Actifed", "Sinutab"],
    "active_ingredients": "Pseudoephedrine HCl 60mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-8004",
    "nafdac_schedule": "schedule_4",
    "nafdac_schedule_date": "2006-01-01",
    "us_dea_schedule": "Not scheduled (but regulated under Combat Methamphetamine Epidemic Act)",
    "uk_controlled_drug_class": "Not controlled (P/GSL)",
    "who_essential_medicine": false,
    "requires_special_prescription": false,
    "requires_physician_only": false,
    "pharmacist_can_prescribe": true,
    "maximum_days_supply": 7,
    "requires_photo_id": true,
    "therapeutic_class": "Decongestant",
    "pharmacological_class": "Sympathomimetic Amine",
    "mechanism_of_action": "Alpha and beta adrenergic agonist, causes vasoconstriction of nasal mucosa",
    "is_controlled": true,
    "is_high_risk": false,
    "requires_monitoring": false,
    "monitoring_type": "Blood pressure, Heart rate (in hypertensive patients)",
    "monitoring_frequency_days": 7,
    "addiction_risk": false,
    "abuse_potential": "low",
    "minimum_age": 12,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": false,
    "major_contraindications": ["Severe hypertension", "Severe coronary artery disease", "MAOIs within 14 days", "Glaucoma"],
    "allergy_cross_reactions": ["Other sympathomimetics", "Ephedrine"],
    "black_box_warning": false,
    "black_box_warning_text": "",
    "major_drug_interactions": ["MAOIs (hypertensive crisis)", "Antihypertensives (reduced effectiveness)", "Digoxin (arrhythmias)", "Beta-blockers (hypertension)"],
    "food_interactions": "Avoid excessive caffeine, take with food if GI upset occurs",
    "search_keywords": ["pseudoephedrine", "sudafed", "decongestant", "nasal congestion", "cold remedy"],
    "generic_variations": ["Pseudoephedrine Hydrochloride", "Pseudoephedrine Sulfate"],
    "common_misspellings": ["Pseudoephedrin", "Sudafed", "Pseudoephedrine"],
    "safer_alternatives": ["Phenylephrine (less effective but not used for meth)", "Nasal saline", "Steam inhalation"],
    "cheaper_alternatives": ["Phenylephrine", "Oxymetazoline nasal spray"],
    "notes": "Effective nasal decongestant but heavily regulated worldwide as precursor for methamphetamine synthesis. NAFDAC requires photo ID, purchase limits, and record-keeping. Behind-the-counter in most countries. Largely replaced by phenylephrine in many OTC products (though phenylephrine is less effective). Causes CNS stimulation, insomnia if taken late in day. Not recommended for extended use (>7 days).",
    "is_active": true
  },
  {
    "generic_name": "Amitriptyline",
    "brand_names": ["Elavil", "Endep", "Tryptanol"],
    "active_ingredients": "Amitriptyline HCl 25mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-8005",
    "nafdac_schedule": "schedule_4",
    "nafdac_schedule_date": "2019-01-01",
    "us_dea_schedule": "Not scheduled",
    "uk_controlled_drug_class": "Not controlled (POM)",
    "who_essential_medicine": true,
    "requires_special_prescription": false,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 30,
    "requires_photo_id": false,
    "therapeutic_class": "Tricyclic Antidepressant (TCA)",
    "pharmacological_class": "Antidepressant/Analgesic",
    "mechanism_of_action": "Inhibits reuptake of serotonin and norepinephrine, anticholinergic effects",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Depression/suicidality (especially first 4 weeks), ECG (QT prolongation), Anticholinergic effects",
    "monitoring_frequency_days": 14,
    "addiction_risk": false,
    "abuse_potential": "low",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": false,
    "major_contraindications": ["Recent MI", "Concurrent MAOIs", "Acute recovery phase of MI", "QT prolongation", "Severe heart block"],
    "allergy_cross_reactions": ["Other tricyclic antidepressants"],
    "black_box_warning": true,
    "black_box_warning_text": "Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants. Close monitoring required especially during initial months of treatment and dose changes.",
    "major_drug_interactions": ["MAOIs (serotonin syndrome, fatal)", "QT-prolonging drugs (arrhythmias)", "Anticholinergics (enhanced effects)", "CNS depressants (sedation)", "Cimetidine (increased TCA levels)", "SSRIs (increased levels)"],
    "food_interactions": "Avoid alcohol, grapefruit juice may increase levels",
    "search_keywords": ["amitriptyline", "elavil", "tricyclic", "depression", "neuropathic pain", "migraine prevention"],
    "generic_variations": ["Amitriptyline Hydrochloride"],
    "common_misspellings": ["Amitryptiline", "Amitriptylin", "Elavill"],
    "safer_alternatives": ["SSRIs (less toxic in overdose)", "SNRIs", "Gabapentin (for pain)"],
    "cheaper_alternatives": ["Imipramine", "Nortriptyline"],
    "notes": "Old tricyclic antidepressant now mainly used for neuropathic pain, migraine prevention, and insomnia (low dose). Very dangerous in overdose (cardiac toxicity). Strong anticholinergic effects (dry mouth, constipation, urinary retention, confusion in elderly). Takes 2-4 weeks for antidepressant effect. NAFDAC scheduled in 2019 due to abuse for sedative effects and suicide attempts. Therapeutic dose 50-150mg for depression, 10-75mg for pain/migraine.",
    "is_active": true
  }
]
